Search Results - Anna Olsson
- Showing 1 - 14 results of 14
-
1
-
2
Prevalence of heavy menstrual bleeding, iron deficiency, iron deficiency anemia, and treatment in women with von Willebrand disease—a cohort study by Linda Myrin–Westesson, Petra Elfvinge, Eva Zetterberg, Anna Olsson
Published in Research and Practice in Thrombosis and Haemostasis (2025-05-01)Get full text
Article -
3
-
4
-
5
-
6
-
7
MRI of the Entire Spinal Cord—Worth the While or Waste of Time? A Retrospective Study of 74 Patients with Multiple Sclerosis by Esben Nyborg Poulsen, Anna Olsson, Stefan Gustavsen, Annika Reynberg Langkilde, Annette Bang Oturai, Jonathan Frederik Carlsen
Published in Diagnostics (2021-08-01)Get full text
Article -
8
-
9
Clinical Management and Outcomes of Immune-Related Adverse Events During Treatment with Immune Checkpoint Inhibitor Therapies in Melanoma and Renal Cell Carcinoma: A UK Real-World... by Anna Olsson-Brown, Ankit Jain, Ricky Frazer, David Farrugia, Judith Carser, John Houghton, Ruth D. Lewis, Simon D’Mello, Gabrielle Emanuel
Published in Oncology and Therapy (2025-05-01)Get full text
Article -
10
Evolving cardiac biomarkers for immune checkpoint inhibitor related myocarditis in cancer patients by Suprateeka Talukder, Aruni Ghose, Turja Chakraborty, Anna Olsson-Brown, Sivatharshini Ramalingam, Stuart D. Rosen, Kate Young, Alexander R. Lyon, Arjun K. Ghosh
Published in International Journal of Cardiology: Heart & Vasculature (2023-12-01)Get full text
Article -
11
Ecological genomics in the Northern krill uncovers loci for local adaptation across ocean basins by Per Unneberg, Mårten Larsson, Anna Olsson, Ola Wallerman, Anna Petri, Ignas Bunikis, Olga Vinnere Pettersson, Chiara Papetti, Astthor Gislason, Henrik Glenner, Joan E. Cartes, Leocadio Blanco-Bercial, Elena Eriksen, Bettina Meyer, Andreas Wallberg
Published in Nature Communications (2024-08-01)Get full text
Article -
12
Cannabis-Based Medicine for Neuropathic Pain and Spasticity—A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial by Julie Schjødtz Hansen, Stefan Gustavsen, Homayoun Roshanisefat, Matthias Kant, Fin Biering-Sørensen, Claus Andersen, Anna Olsson, Helene Højsgaard Chow, Nasrin Asgari, Julie Richter Hansen, Helle Hvilsted Nielsen, Rikke Middelhede Hansen, Thor Petersen, Annette Bang Oturai, Finn Sellebjerg, Eva Aggerholm Sædder, Helge Kasch, Peter Vestergaard Rasmussen, Nanna Brix Finnerup, Kristina Bacher Svendsen
Published in Pharmaceuticals (2023-07-01)Get full text
Article -
13
506 IGNYTE: an open-label, multicenter, phase 1/2 (Ph 1/2) clinical trial of RP1 ± nivolumab in patients with advanced solid tumors by Anna Olsson-Brown, Joseph Sacco, Mark Middleton, Jason Chesney, Mohammed Milhem, Kevin Harrington, Robert Coffin, Katy Tsai, Adel Samson, Bartosz Chmielowski, Ari VanderWalde, Andrea Pirzkall, Jiaxin Niu, Praveen Bommareddy, Georgia Beasley, Gino In, Terence Rhodes, Francesca Aroldi, Lavita Menezes, Tawnya Bowles, Hamid Emamekhoo, Scott Baum, Sophie Dalac-Rat, Katharina Kahler, Eva Muñoz
Published in Journal for ImmunoTherapy of Cancer (2021-11-01)Article -
14
Nonneutralizing antibodies in Nordic persons with moderate hemophilia A and B (the MoHem study) by Ragnhild J. Måseide, MD, PhD, Erik Berntorp, MD, PhD, Jan Astermark, MD, PhD, Anna Olsson, MD, PhD, Maria Bruzelius, MD, PhD, Tony Frisk, MD, PhD, Vuokko Nummi, MD, PhD, Riitta Lassila, MD, PhD, Karin Strandberg, MD, PhD, Geir E. Tjønnfjord, MD, PhD, Pål A. Holme, MD, PhD
Published in Research and Practice in Thrombosis and Haemostasis (2024-11-01)Get full text
Article
